 |
|
Asking and Answering the Critical Questions in Hematologic Malignancies
A PRIME Oncology Satellite Symposium at EHA 2009
4 June 2009 | Berlin, Germany |
|
Faculty |
Co-Chairs:
|
Andreas Hochhaus, MD
Medizinische Fakultaet Mannheim
Heidelberg University
Mannheim, Germany
Hagop Kantarjian, MD
M. D. Anderson Cancer Center
Houston, Texas, United States
|
| Faculty: |
Anders Österborg, MD, PhD
Karolinska Hospital
Stockholm, Sweden
Adrian Newland, MD
Barts and the London NHS Trust
The Royal London Hospital
London, United Kingdom
Jesús F. San Miguel, MD, PhD
University Hospital of Salamanca
Salamanca, Spain
Aristoteles Giagounidis, MD, PhD
St. Johannes Hospital
Duisburg, Germany
|
|
 Agenda |
| 8:00 |
|
Welcome and Introduction
Co-chairs: Andreas Hochhaus, MD & Hagop Kantarjian, MD
|
| 8:00 |
|
Clinical Opinion Poll
|
| 8:05 |
|
Emerging Role of Novel Antibody Therapy in Refractory Chronic Lymphocytic Leukemia
Anders Österborg, MD, PhD
|
| 8:20 |
|
Clinical Opinion Poll
|
| 8:25 |
|
Treatment of Patients With Relapsed Myeloma: Current and Emerging Therapies
Jesús F. San Miguel, MD, PhD
|
| 8:40 |
|
Clinical Opinion Poll
|
| 8:45 |
|
Imatinib-Resistant/Intolerant Chronic Myelogenous Leukemia: Optimizing the Efficacy of Second Generation Tyrosine Kinase Inhibitors
Andreas Hochhaus, MD
|
| 9:00 |
|
Clinical Opinion Poll
|
| 9:05 |
|
Idiopathic Thrombocytopenic Purpura: New Therapies for Relapsing Disease
Adrian Newland, MD
|
| 9:20 |
|
Clinical Opinion Poll
|
|
9:25
|
|
Myelodysplastic Syndromes: Risk-Based Choice of Therapy
Hagop Kantarjian, MD
|
| 9:40 |
|
Clinical Opinion Poll
|
| 9:45 |
|
Transfusion-Dependent Myelodysplastic Syndrome: Managing Iron Overload
Aristoteles Giagounidis, MD, PhD
|
| 10:00 |
|
Concluding Remarks/Adjourn
Andreas Hochhaus, MD & Hagop Kantarjian, MD
|
|
|
|
|
Support | Financial support has been provided by GlaxoSmithKline.
 |
|
